Loading...
Loading...
Shares of Amarin
AMRN are higher on the session by 8.64%, currently trading at $13.20. The stock has been moving largely higher over the past few days and is currently testing the 50-day moving average.
Options traders are buying calls on the name today. A short while ago the September 2011 $20.00 call traded 19,000 times on open interest of 32,688 contracts.
Overall call volume is now running at 7.18x the daily average with 77% of all calls traded being purchases on the offer.
Amarin Corporation plc is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in